5th Balkan Venous Forum & National Meeting of BNSAVS

Last update: 05.10.2014

Organized by:
BVF, BNSAVS

Place:
Kempinski Hotel Zografski

City:
Sofia

Start date:
14.10.2008

End date:
14.10.2011

App. Nr. of HCP:
n.a.

Specialists:
vascular surgery, angiology and phlebology

Website:
http://bvf.bnsavs.org/

Any practice that might create confusion about the real scientific and educational purpose of scientific events sponsored by industry or to which industry sponsors HCPs should not be tolerated.

ARPharM pre-assessment:

(Date (dd.mm.yyyy)): 09.07.2014)

Scientific Programme Schedule / Structure
http://bvf.bnsavs.org/?page_id=23 - The programme available is incomplete – the full programme should be available 3 months in advance of the event, at the latest; the detailed programme must include a timetable, the themes that speakers will address, and the duration of any breaks; unnecessarily duplications in the scientific programme must be avoided. EFPIA Code Article 94 ARPharM Article 9 – Section 9.1

Location and Venue

Hospitality Provided (Directly or Indirectly) to HCP
The available information on the event's website is not definitive yet and would not allow a pre-assessment.

Other Activities
http://bvf.bnsavs.org/?page_id=122 - Entertainment, sporting or leisure events are organised in connection with the event – hospitality provided (directly or indirectly) to HCP must be limited to participation in registration fees, travel expenses, meals, overnight stay; hospitality shall not include sponsoring or organising of sporting or leisure events or other entertainment events. Articles 94 & 95 Article 9 – Section 9.7

Accompanying Persons
The available information on the event's website is not definitive yet and would not allow a pre-assessment.

return; 1

Legend:

ARPharM’s pre-assessment process is ongoing.

based on information provided through one of the ways described above (on the date indicated), arrangements would not raise concern with regard to provisions of the ARPharM Article 9 Code of Ethics provisions.

based on information provided through one of the ways described above (on the date indicated), arrangements may raise concern with regard to provisions of the ARPharM Article 9 Code of Ethics provisions.

It is always recommended to check the rules prevailing under applicable national codes. EXHIBITIONS – please read carefully the provisions of the ARPHARM HCP Code and the additional guidance.